AMSNY Opposes Proposed Cuts to Diversity in Medicine Pipeline Programs
The New York State Executive Budget for FY19 includes a 20% cut to diversity in medicine pipeline programs. This comes on top of a 22.5% cut in FY18.
New York already has a big diversity gap: underrepresented minorities (Black/African Americans and Hispanic/Latinos) make up approximately 31% of the population but only 12% of the state’s physician workforce. A lack of diversity leads to worse health outcomes for NY’s diverse residents. But this problem won’t fix itself, as barriers prevent many individuals from underrepresented backgrounds who are interested in becoming doctors from pursuing their dreams.
AMSNY’s diversity programs create opportunities for those students: between 94% and 97% of students in AMSNY post-collegiate programs have gone on to become doctors. A 20% cut would mean that one in five of future AMSNY students from underrepresented backgrounds would not have an opportunity to become a doctor and improve healthcare.
2017-2018 New York State Legislative Session
AMSNY supports A.6820 (Gunther) – S.4611 (Murphy), which would provide tax credit incentives to clinical preceptors providing invaluable educational experiences and mentoring to medical and allied health professions students at New York State academic institutions. Read more here.
AMSNY supports A.3126 (Gottfried) – S.2546 (Hannon), which would require that the New York State Department of Health (NYSDOH) pay 100 percent of eligible public hospitals medical assistance and uninsured patient losses. Under current statute, NYSDOH is “authorized” rather than required to pay “up to” 100 percent of such payments. Read more here.
NYSTEM & AMSNY
Since 2007, AMSNY has played a key role in advocating for the creation and funding the New York State Stem Cell Science program to foster a strong stem cell research community in New York State and to accelerate the growth of scientific knowledge about stem cell biology and the development of therapies and diagnostic methods. Learn more here.